Effects of Alendronate on Osteoarthritis in Rats

Rui GU,Liaobin CHEN,Hui WANG,Aixin HU,Yang TAN
2009-01-01
Abstract:Objective: To explore the effects of Alendronate (ALN) on experimental osteoarthritis in rats. Methods: Animal models of osteoarthritis were obtained in rats by intra-articular injection of 4% chymopapain for three times. Forty rats were divided into five groups (eight in each group) as normal group, model group and three ALN treatment groups (0. 12, 0. 6 and 3. 0 mg/kg per week orally). Both normal group and model group were fed with normal saline. All animals were killed after being treated for seven weeks. Cartilage changes were evaluated. Macroscopic, histological, chemistry and immuno-histologic analysis were performed on the articular cartilage. Results: ALN was chondro-protective at high concentration in histology. ALN in a dosage of 0. 6 mg/kg or 3. 0 mg/kg per week reduced the expression of matrix metalloproteinases-3, -9, and tissue inhibitor of metalloproteinase-1 (P<0. 01) in a dose-dependent manner, furthermore, they prevent the reduction of proteoglycan (PG) contents (P<0. 01) in a dose-dependent manner. Conclusion; ALN appears to provide some chondro-protection in a dose-dependent manner in this model. The mechanisms are related to the reduction of expression of matrix metalloproteinases-3, -9, and tissue inhibitor of metalloproteinase-1, and preventing the reduction of proteoglycan contents.
What problem does this paper attempt to address?